Newsletter
But let’s see where it comes from.
Blood test provider Medichecks has unveiled its new pathology platform, Plasma, at the Digital Healthcare Show 2023, increasing the diagnostic capability of blood tests.
Plasma will enable the NHS, GPs, pharmacies, fertility clinics and other healthcare providers to meet increased demand for pathology testing solutions.
Flexible solutions allow partners to select from a ready-made catalog of around 100 tests, through finger prick and venous blood collection. Alternatively, tests can be tailored to requirements.
Users will also have access to more than 200 partner phlebotomy clinics nationwide, if needed, while receiving results from the brand’s network of accredited laboratories.
Medichecks believes the new platform has the potential to enable the UK healthcare system to evolve by enabling diagnostics as a service.
Dr Sam Rodgers, Chief Medical Officer at Medichecks, said: “Remote blood testing has the potential to reduce the strain on healthcare systems and focus service delivery where it is most needed.
“Expanding access to diagnostic and digitization services is long overdue. COVID-19 proved that delivering healthcare through digital channels really works and, most importantly, is more accessible and convenient for patients.
“We know there were fears that expanding remote healthcare testing would fuel health anxiety and increase the burden on already stretched services, but our data shows the opposite is true.”
A three-month NHS trial involving the provision of 37,000 CE-marked finger-prick blood tests to volunteers in England found that 94% of recipients rated their Medichecks experience as to good or excellent.
Supporting flexible diagnostic testing as a service, Plasma is delivered through an intuitive digital portal that can be plugged into existing system APIs. Customizable branding, communications and white label packages are available through the portal.
Earlier this year, Macmillan Cancer Support invested in Neutrocheck, a wearable device and app centered around an at-home finger prick test to detect neutropenic sepsis in cancer patients.
Source link
Ikaroa is proud to announce that Medichecks has unveiled its newest innovative pathology platform “Plasma”. Plasma is a digitally-enabled cloud-based software which increases the efficiency, accuracy, and speed of Medichecks pathology services.
Using advanced technologies such as artificial intelligence, advanced algorithms and machine learning, Plasma is designed to help Medichecks streamline and manage their pathologies, making access to advanced diagnostic services faster and more cost-effective. Plasma provides improved accuracy in test results and increases the amount of data accessible to clinicians.
The platform also offers improved visibility into findings as well as a central hub for archiving, searching and downloading all pathology results. With the support of highly secure data storage and access, Medichecks is able to provide cutting-edge analytics, reduce errors, and unlock new pathways for personalized patient care.
At Ikaroa, we are delighted to see this new and innovative platform from Medichecks, which is set to revolutionize pathology process in the healthcare industry. We are proud to be a partner in this endeavor and look forward to contributing to Medichecks’ success.
